Mahdi Hesaraki

Dr. Mahdi Hesaraki

orcid

Research Focus & Metrics

Academic Career Length

9Years (2018-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
21 March 2024 in Life
Verified
Journal Article
Open access
PDF file
MCMahla Chalak
Mahla Chalak
MHMahdi Hesaraki
Mahdi Hesaraki
SMSeyedeh Nasim Mirbahari
Seyedeh Nasim Mirbahari
MYMeghdad Yeganeh
Meghdad Yeganeh
SAShaghayegh Abdi
Shaghayegh Abdi
Farhid HemmatzadehFarhid Hemmatzadeh
Farhid Hemmatzadeh
Cells are very important to researchers due to their use in various biological studies in in vitro and in vivo settings. This importance stems from the short lifespan of most cells under laboratory conditions, which can pose significant challenges, such as the difficulties associated with extraction from the source tissue, ethical concerns about separating cells from human or animal models, limited cell passage ability, and variation in results due to differences in the source of the obtained cells, among other issues. In general, cells in laboratory conditions can divide into a limited number, known as the Hayflick limit, due to telomere erosion at the end of each cellular cycle. Given this problem, researchers require cell lines that do not enter the senescence phase after a limited number of divisions. This can allow for more stable studies over time, prevent the laborious work associated with cell separation and repeated cultivation, and save time and money in research projects. The aim of this review is to summarize the function and effect of immortalization techniques, various methods, their advantages and disadvantages, and ultimately the application of immortalization and cell line production in various research fields.

1 March 2021 in Basic and Clinical Neuroscience Journal
Verified
Journal Article
Open access
KNKeivan Nedaei
Keivan Nedaei
MHMahdi Hesaraki
Mahdi Hesaraki
SMSaeideh Mazloomzadeh
Saeideh Mazloomzadeh
MTMehdi Totonchi
Mehdi Totonchi
ABAlireza Biglari
Alireza Biglari
Introduction: Semaphorin 3A (Sema 3A) is a secreted protein, which plays an integral part in developing the nervous system. It has collapse activity on the growth cone of dorsal root ganglia. After the development of the nervous system, Sema 3A expression decreases. Neuropilin 1 is a membrane receptor of Sema 3A. When semaphorin binds to neuropilin 1, the recruitment of oligodendrocyte precursor cells to the demyelinated site decreases. In Multiple Sclerosis (MS), Sema 3A expression increases and inhibits oligodendrocyte precursor cell differentiation. Therefore, the remyelination of axons gets impaired. We hypothesized that the function of Sema 3A could be inhibited by neutralizing its binding to membrane NRP1. Methods: we cloned a soluble form of mouse Neuropilin 1 (msNRP1) in a lentiviral vector and expressed the recombinant protein in HEK293T cells. Then, the conditioned medium of the transduced cells was used to evaluate the effects of the msNRP1 on the inhibition of Sema 3A-induced growth cone collapse activity. Dorsal root ganglion explants of timed pregnant (E13) mice were prepared. Then, the growth cone collapse activity of Sema 3A was assessed in the presence and absence of msNRP1-containing conditioned media of transduced and non-transduced HEK293T cells. Comparisons between groups were performed by 1-way ANOVA and post hoc Tukey tests. Results: msNRP1 was successfully cloned and transduced in HEK293T cells. The supernatant of transduced cells was concentrated and evaluated for the production of msNRP1. ELISA results indicated that transduced cells secreted msNRP1. Growth cone collapse assay showed that Sema 3A activity was significantly reduced in the presence of the conditioned medium of msNRP1-transduced HEK293T cells. Conversely, a conditioned medium of non-transduced HEK293T cells could not effectively prevent Sema 3A growth cone collapse activity. Conclusion: Our results indicated that msNRP1 was successfully produced in HEK293T cells. The secreted msNRP1 effectively prevented Sema 3A collapse activity. Therefore, msNRP1 can increase remyelination in MS lesions, although more studies using animal models are required.

1 September 2018
Verified
Journal Article
Open access
ASAzam Samadian
Azam Samadian
MHMahdi Hesaraki
Mahdi Hesaraki
SMSepideh Mollamohammadi
Sepideh Mollamohammadi
BABehrouz Asgari
Behrouz Asgari
MTMehdi Totonchi
Mehdi Totonchi
HBHossein Baharvand
Hossein Baharvand
Dual inhibition of mitogen-activated protein kinase (MAPK) kinase (also known as MEK) and transforming growth factor β (TGFβ) type I receptors by PD0325901 and SB431542, known as R2i has been introduced as a highly efficient approach to the generation of mouse embryonic stem cells (ESC). In the present study, we investigated the molecular mechanisms underlying ESC derivation in the R2i condition. In this experimental study, zona-free whole E3.5 blastocysts were seeded on mouse embryonic fibroblast (MEF) feeder cells in both R2i and serum conventional media. The isolated inner cell mass (ICM), ESCs and the ICM-outgrowths were collected on days 3, 5 and 7 post-blastocyst culture for quantitative real timepolymerase chain reaction (qRT-PCR) analysis as well as to assess the DNA methylation status at the time points during the transition from ICM to ESC. qRT-PCR revealed a significantly higher expression of the pluripotency-related genes (Oct4, Nanog, Sox2, Rex1, Dppa3, Tcf3, Utf1, Nodal, Dax1, Sall4 and β-Catenin) and lower expression of early differentiation genes (Gata6, Lefty2 and Cdx2) in R2i condition compared to the serum condition. Moreover, the upstream region of Oct4 and Nanog showed a progressive increase in methylation levels in the upstream regions of the genes following in R2i or serum conditions, followed by a decrease of DNA methylation in ESCs obtained under R2i. However, the methylation level of ICM outgrowths in the serum condition was much higher than R2i, at levels that could have a repressive effect and therefore explain the absence of expression of these two genes in the serum condition. Our investigation revealed that generation of ESCs in the ground-state of pluripotency could be achieved by inhibiting the MEK and TGF-β signaling pathways in the first 5 days of ESC derivation.

1 January 2025 in BioMed Research International
Verified
Journal Article
Open access
MHMahdieh Hashemi
Mahdieh Hashemi
MHMahdi Hesaraki
Mahdi Hesaraki
RRRoya Ramezankhani
Roya Ramezankhani
Seyyed Mohammad YaghoubiSeyyed Mohammad Yaghoubi
Seyyed Mohammad Yaghoubi
BSBahare Shokouhian
Bahare Shokouhian
Massoud VosoughMassoud Vosough
Massoud Vosough
Objective: Despite the remarkable advances in approved therapeutic approaches, the recurrence rate of hepatocellular carcinoma (HCC) is very high after treatment. Therefore, introducing innovative therapeutic modalities such as targeted molecular therapies is inevitable. Lysine demethylase 6A ( KDM6A ) is a member of the KDM6 family with histone demethylase activity. This gene frequently mutates in different cancers, and its mutations are associated with the increased likelihood of carcinogenesis. This study is aimed at evaluating if inducing KDM6A expression could attenuate cancerous features of HCC cells. Method: A lentiviral‐based vector was used to induce KDM6A expression in Huh‐7 cells. The impact of KDM6A overexpression on the cancerous phenotype of HCC cells was assessed by measuring proliferation rate, migration and colony formation capacity, and differentiation induction toward hepatocytes. Results: KDM6A overexpression significantly altered cellular morphology, proliferation rate, cell cycle pattern, colony formation, and migration capacity of HCC cells. In addition, induction of differentiation toward hepatocytic fate resulted in down/upregulation of epithelial–mesenchymal transition (EMT) markers associated with the cadherin switch. Furthermore, the expressions of ALB and HNF4α , key hepatocytic hallmarks, were increased. Conclusion: Overexpression of KDM6A could be used as a potential noninvasive molecular therapeutic strategy to prevent metastasis and recurrence rate in HCC.

30 July 2026 in Biomedicine Advances
Verified
Journal Article
Open access
PDF file
MHMahdi Hesaraki
Mahdi Hesaraki
FHFatemeh Haghdoost
Fatemeh Haghdoost
BMBenyamin Mashhadi
Benyamin Mashhadi
AZArmin Nazemi Zadeh
Armin Nazemi Zadeh
FSFereshteh Sarafrazi
Fereshteh Sarafrazi
Regenerative medicine examines how to use stem cells, growth factors, cellular dressings, skin substitutes, biopolymers, hydrogels, exosome-based systems, and nanoparticle-enabled delivery platforms to improve Wound Healing. It is increasingly shaping the therapeutic and conceptual approach to wound care by shifting the goal of treatment from simple wound closure to the restoration of functional tissue. This review discusses the biological rationale of wound healing. The normal process of wound healing includes several coordinated and overlapping phases of hemostasis, inflammation, proliferation, and remodeling. This sequence often is disrupted in burns, diabetic ulcers, infected wounds, and extensive traumatic injuries, which leads to chronic inflammation, delayed vascularization, defective extracellular matrix deposition, or poor epithelial regeneration. Regenerative strategies, by providing instructive cells, paracrine signals, structural scaffolds, or controlled local delivery of bioactive molecules, try to correct these failures. Regenerative medicine has seen significant advances with the development of living skin substitutes, growth factor-loaded matrices, dynamic hydrogels, electrospun nanofibers, bioprintable bioinks, and smart wound dressings. However, the variability of biomaterial composition, poor regeneration of vascular and appendages, manufacturing complexity, cost, safety concerns, and the need for standardized potency assays still limit clinical translation. A more integrated approach that combines biological signaling, scaffold design, antimicrobial control, and patient-specific wound assessment may help bridge the gap between promising experimental systems and clinically reliable regenerative wound therapies.

30 September 2025 in International Journal of Basic Science in Medicine
Verified
Journal Article
Closed access
FGFatemeh Hosseini Ghaemi
Fatemeh Hosseini Ghaemi
AZArmin Nazemi Zadeh
Armin Nazemi Zadeh
FYFarshid Yekani
Farshid Yekani
MMMaryam Malekzadeh
Maryam Malekzadeh
MHMahdi Hesaraki
Mahdi Hesaraki
SRSarah Rajabi
Sarah Rajabi
For centuries, there has been ongoing effort to regenerate living organs using tissues or their cells. Organoid technology involves the three-dimensional (3D) culture of various cell types, derived from tissue explants, tumors, stem cells, or other progenitor cells, which self-organize under controlled conditions to mimic the structure and function of real organs. Two-dimensional (2D) culture is the most exploited in vitro method providing advantages in terms of reproducibility, high throughput and cost- effectiveness. Even so, 2D culture generally fails to mimic a tissue or organ that possesses a defined 3D structure along with complicated intercellular communication. In fact, these cells are cultured in an environment similar to the body’s extracellular matrix. These organoids differentiate into functional cell types, acquiring the complexity of an organ’s anatomy and physiology. This innovative technology has revolutionized research and medicine, offering a powerful alternative to animal models in preclinical studies. Organoids have shown great promise in various therapeutic and research applications, although they are not without limitations. Despite these challenges, their potential and necessity in advancing biomedical research are undeniable. This review aims to explore both the applications and the challenges associated with organoid technology.